View in EDS HTML Full Text PDF Full Text

Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.

Saved in:
Bibliographic Details
Title: Roflumilast Cream 0.3% in Patients with Chronic Plaque Psoriasis: Pooled PASI and PASI-HD Results from the DERMIS Phase III Trials.
Authors: Papp, Kim A.1,2 (AUTHOR) kapapp@probitymedical.com, Del Rosso, James Q.3 (AUTHOR), Lebwohl, Mark G.4 (AUTHOR), Gooderham, Melinda J.5,6,7 (AUTHOR), Hebert, Adelaide A.8 (AUTHOR), Hong, H. Chih-ho9,10 (AUTHOR), Kircik, Leon H.4,11,12,13 (AUTHOR), Pariser, David M.14 (AUTHOR), Stein Gold, Linda15 (AUTHOR), Strober, Bruce16 (AUTHOR), Seal, Melissa S.17 (AUTHOR), Krupa, David17 (AUTHOR), Chu, David H.17 (AUTHOR), Burnett, Patrick17 (AUTHOR), Berk, David R.17 (AUTHOR), Higham, Robert C.17 (AUTHOR)
Source: Dermatology & Therapy. Dec2025, Vol. 15 Issue 12, p3733-3744. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-025-01562-4